FindTrial
Sign In

The value of multi-target fecal FIT-DNA combined detection technology on colorectal neoplastic lesions

The value of multi-target fecal FIT-DNA combined detection technology on colorectal neoplastic lesions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060076
Enrollment
Unknown
Registered
2022-05-18
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonrectal cancer

Interventions

Gold Standard:colonoscopy and pathological biopsy
Index test:multi-target fecal FIT-DNA detection technique

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 70 years. 2. Patients with colorectal tumors found by colonoscopy and pathological manifestations of cancer and adenoma.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors of other systems. 2. Patients with contraindications to colonoscopy.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactZhang Chuan

Beijing Tongren Hospital, Capital Medical University

digestivezhang@163.com+86 10 5826 8667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026